Intestinal phosphate absorption in a model of chronic renal failure

Kidney International

Volumn 72, Issue 2, 2007, Pages 166-173

  Marks, J ^a   Churchill, L J ^a   Srai, S K ^a   Biber, J ^b   Murer, H ^b   Jaeger, P ^a   Debnam, E S ^a   Unwin, R J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chronic renal failure; Intestine; Phosphate uptake

Indexed keywords

MESSENGER RNA; PHOSPHATE; SODIUM GLUCOSE COTRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DUODENUM; HYPERPHOSPHATEMIA; INTESTINE ABSORPTION; INTESTINE VILLUS; JEJUNUM; MESSENGER RNA SYNTHESIS; NONHUMAN; PHOSPHATE BALANCE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SMALL INTESTINE MUCOSA;

ANIMALS; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HYPOPHOSPHATEMIA; INTESTINAL ABSORPTION; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34447518600     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002292     Document Type: Article

References (67)

1. Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch 2004; 447: 763-767.
2. Collins JF, Ghishan FK. Molecular cloning, functional expression, tissue distribution, and in situ hybridization of the renal sodium phosphate (Na+/P(i)) transporter in the control and hypophosphatemic mouse. FASEB J 1994; 8: 862-868.
3. Custer M, Lotscher M, Biber J et al. Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry. Am J Physiol 1994; 266: F767-F774.
4. Murer H, Hernando N, Forster I, Biber J. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 2000; 80: 1373-1409.
5. Murer H, Hernando N, Forster I, Biber J. Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol 2003; 65: 531-542.
6. Segawa H, Kaneko I, Takahashi A et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 2002; 277: 19665-19672.
7. Murer H, Hernando N, Forster L, Biber J. Molecular mechanisms in proximal tubular and small intestinal phosphate reabsorption (plenary lecture). Mol Membr Biol 2001; 18: 3-11.
8. Walling MW. Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites. Am J Physiol 1977; 233: E488-E494.
9. Danisi G, Murer H. Inorganic phosphate absorption in small intestine, chap. 12, In: Field M, Fizzel RA (eds). American physiological society, Handbook of Physiology. The Gastrointestinal System. Vol IV, edn. 1991, pp 323-336, Oxford University press: New York.
10. Radanovic T, Wagner CA, Murer H, Biber J. Regulation of intestinal phosphate transport. I. Segmental expression and adaptation to low-P(i) diet of the type IIb Na(+)-P(i) cotransporter in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2005; 288: G496-G500.
11. Stauber A, Radanovic T, Stange G et al. Regulation of intestinal phosphate transport. II. Metabolic acidosis stimulates Na(+)-dependent phosphate absorption and expression of the Na(+)-P(i) cotransporter NaPi-IIb in small intestine. Am J Physiol Gastrointest Liver Physiol 2005; 288: G501-G506.
12. Marks J, Srai SK, Biber J et al. Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice. Exp Physiol 2006; 91: 531-537.
13. Goodman WG. Medical management of secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant 2003; 18(Suppl 3): 2-8.
14. Indridason OS, Quarles LD. Hyperphosphatemia in end-stage renal disease. Adv Ren Replace Ther 2002; 9: 184-192.
15. Brooks DP, Ali SM, Contino LC et al. Phosphate excretion and phosphate transporter messenger RNA in uremic rats treated with phosphonoformic acid. J Pharmacol Exp Ther 1997; 281: 1440-1445.
16. Peerce BE, Weaver L, Clarke RD. Effect of 2′-phosphophloretin on renal function in chronic renal failure rats. Am J Physiol Renal Physiol 2004; 287: F48-F56.
17. Loghman-Adham M, Szczepanska-Konkel M, Dousa TP. Phosphate transport in brush border membranes from uremic rats. Response to phosphonoformic acid. J Am Soc Nephrol 1992; 3: 1253-1259.
18. Loghman-Adham M. Renal and intestinal Pi transport adaptation to low phosphorus diet in uremic rats. J Am Soc Nephrol 1993; 3: 1930-1937.
19. Albaaj F, Hutchison A. Hyperphosphataemia in renal failure: causes, consequences and current management. Drugs 2003; 63: 577-596.
20. Xu H, Uno JK, Inouye M et al. Regulation of intestinal NaPi-IIb cotransporter gene expression by estrogen. Am J Physiol Gastrointest Liver Physiol 2003; 285: G1317-G1324.
21. Debnam ES, Smith MW, Sharp PA et al. The effects of streptozotocin diabetes on sodium-glucose transporter (SGLT1) expression and function in rat jejunal and ileal villus-attached enterocytes. Pflugers Arch 1995; 430: 151-159.
22. O'Riordan DK, Sharp P, Sykes RM et al. Cellular mechanisms underlying the increased duodenal iron absorption in rats in response to phenylhydrazine-induced haemolytic anaemia. Eur J Clin Invest 1995; 25: 722-727.
23. Bikle DD, Munson S. The villus gradient of brush border membrane calmodulin and the calcium-independent calmodulin-binding protein parallels that of calcium-accumulating ability. Endocrinology 1986; 118: 727-732.
24. Goldstein DA, Horowitz RE, Petit S et al. The duodenal mucosa in patients with renal failure: response to 1,25(OH)2D3. Kidney Int 1981; 19: 324-331.
25. Shousha S, Bull TB, Parkins RA. Duodenal ultrastructure in patients with chronic renal failure with a comment on the incidence of Campylobacter pylori infection. Ultrastruct Pathol 1990; 14: 1-10.
26. Arvanitakis C, Nakos V, Kalekou-Greka H, Tourkantonis A. Small intestinal function and structure in patients with chronic renal failure. Clin Nephrol 1988; 29: 235-243.
27. Bronner F. Mechanisms of intestinal calcium absorption. J Cell Biochem 2003; 88: 387-393.
28. Bacic D, Lehir M, Biber J et al. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney Int 2006; 69: 495-503.
29. Traebert M, Roth J, Biber J et al. Internalization of proximal tubular type II Na-P(i) cotransporter by PTH: immunogold electron microscopy. Am J Physiol Renal Physiol 2000; 278: F148-F154.
30. Imanishi Y, Koyama H, Inaba M et al. Phosphorus intake regulates intestinal function and polyamine metabolism in uremia. Kidney Int 1996; 49: 499-505.
31. Onishi T, Bone III HG, Catherwood BD, Deftos LJ. A rat model for hormone and mineral changes in chronic renal failure. Proc Soc Exp Biol Med 1983; 174: 193-197.
32. Nagano N, Miyata S, Abe M et al. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 2006; 69: 531-537.
33. Lee DB, Walling MW, Corry DB. Phosphate transport across rat jejunum: influence of sodium, pH, and 1,25-dihydroxyvitamin D3. Am J Physiol 1986; 251: G90-G95.
34. Nemere I, Larsson D. Does PTH have a direct effect on intestine? J Cell Biochem 2002; 86: 29-34.
35. Levi M, Lotscher M, Sorribas V et al. Cellular mechanisms of acute and chronic adaptation of rat renal P(i) transporter to alterations in dietary P(i). Am J Physiol 1994; 267: F900-F908.
36. Hattenhauer O, Traebert M, Murer H, Biber J. Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol 1999; 277: G756-G762.
37. Huber K, Walter C, Schroder B, Breves G. Phosphate transport in the duodenum and jejunum of goats and its adaptation by dietary phosphate and calcium. Am J Physiol Regul Integr Comp Physiol 2002; 283: R296-R302.
38. Radanovic T, Wagner CA, Murer H, Biber J. Regulation of intestinal phosphate transport. I. Segmental expression and adaptation to low-P(i) diet of the type IIb Na(+)-P(i) cotransporter in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2005; 288: G496-G500.
39. Danisi G, Caverzasio J, Trechsel U et al. Phosphate transport adaptation in rat jejunum and plasma level of 1,25-dihydroxyvitamin D3. Scand J Gastroenterol 1990; 25: 210-215.
40. Haussler MR, Baylink DJ, Hughes MR et al. The assay of 1alpha, 25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol 1976; 5(Suppl): 151S-165S.
41. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277: F157-F175.
42. Li YC, Pirro AE, Demay MB. Analysis of vitamin D-dependent calcium-binding protein messenger ribonucleic acid expression in mice lacking the vitamin D receptor. Endocrinology 1998; 139: 847-851.
43. Capuano P, Radanovic T, Wagner CA et al. Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. Am J Physiol Cell Physiol 2005; 288: C429-C434.
44. Segawa H, Kaneko I, Yamanaka S et al. Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 2004; 287: F39-F47.
45. Tessitore N, Venturi A, Adami S et al. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Miner Electrolyte Metab 1987; 13: 38-44.
46. Prince RL, Hutchison BG, Kent JC et al. Calcitriol deficiency with retained synthetic reserve in chronic renal failure. Kidney Int 1988; 33: 722-728.
47. Portale AA, Booth BE, Halloran BP, Morris Jr RC. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984; 73: 1580-1589.
48. Martin DR, Ritter CS, Slatopolsky E, Brown AJ. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab 2005; 289: E729-E734.
49. Ritter CS, Martin DR, Lu Y et al. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res 2002; 17: 2206-2213.
50. Miyamoto K, Ito M, Segawa H, Kuwahata M. Secondary hyperparathyroidism and phosphate sensing in parathyroid glands. J Med Invest 2000; 47: 118-122.
51. Loghman-Adham M. Adaptation to changes in dietary phosphorus intake in health and in renal failure. J Lab Clin Med 1997; 129: 176-188.
52. Fukagawa M, Nii-Kono T, Kazama JJ. Role of fibroblast growth factor 23 in health and in chronic kidney disease. Curr Opin Nephrol Hypertens 2005; 14: 325-329.
53. Imel EA, Econs MJ. Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol 2005; 16: 2565-2575.
54. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
55. Shimada T, Muto T, Urakawa I et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 2002; 143: 3179-3182.
56. Miyamoto K, Ito M, Kuwahata M et al. Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 2005; 9: 331-335.
57. Perwad F, Azam N, Zhang MY et al. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 2005; 146: 5358-5364.
58. Yu X, Sabbagh Y, Davis SI et al. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone 2005; 36: 971-977.
59. Larsson T, Nisbeth U, Ljunggren O et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003; 64: 2272-2279.
60. Saito H, Maeda A, Ohtomo S et al. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 2005; 280: 2543-2549.
61. Tryfonidou MA, Stevenhagen JJ, van den Bemd GJ et al. Moderate cholecalciferol supplementation depresses intestinal calcium absorption in growing dogs. J Nutr 2002; 132: 2644-2650.
62. Nemere I. 24,25-dihydroxyvitamin D3 suppresses the rapid actions of 1, 25-dihydroxyvitamin D3 and parathyroid hormone on calcium transport in chick intestine. J Bone Miner Res 1999; 14: 1543-1549.
63. Zhao B, Nemere I. 1,25(OH)2D3-mediated phosphate uptake in isolated chick intestinal cells: effect of 24,25(OH)2D3, signal transduction activators, and age. J Cell Biochem 2002; 86: 497-508.
64. Khanal RC, Smith NM, Nemere I. Phosphate uptake in chick kidney cells: Effects of 1,25(OH)(2)D(3) and 24,25(OH)(2)D(3). Steroids 2006; 72: 158-164.
65. Cunningham J. Management of secondary hyperparathyroidism. Ther Apher Dial 2005; 9(Suppl 1): S35-S40.
66. Eto N, Miyata Y, Ohno H, Yamashita T. Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrol Dial Transplant 2005; 20: 1378-1384.
67. Loghman-Adham M, Motock GT. Use of phosphonoformic acid to induce phosphaturia in chronic renal failure in rats. Ren Fail 1996; 18: 855-866.